Glatiramer acetate

This classification denotes a biological response modifier with the molecular formula (C9H9NO2)n.(C6H12N2O)n.(C5H7NO3)n.(C3H5NO)n.C2H4O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5M691HL4BO, chemically known as l-glutamic acid polymer with l-alanine, l-lysine and l-tyrosine, acetate (salt) but generally known as glatiramer acetate, which bears US NIH Compound Identifier 3081884. European Medicines Agency schedules Glatiramer acetate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13971MIG. World Health Organization schedules glatiramer acetate in its Anatomical Therapeutic Chemical (ATC) Classification. As of Q4 2014, GLATIRAMER ACETATE remains the US FDA Preferred Term for this commodity. Glatiramer acetate bears US NLM identifiers UMLS ID C0289884 and NCI Concept Code C65805. SMILES: CC(C(=O)O)N.CC(=O)O.C1=CC(=CC=C1CC(C(=O)O)N)O.C(CCN)CC(C(=O)O)N.C(CC(=O)O)C(C(=O)O)N.